# Nephron commits to $400M syringe purchase from Sharps Technology

Nephron Pharmaceuticals committed to minimum orders of over $400 million over 10 years from Sharps Technology for copolymer prefillable syringe systems, with first-year revenue of about $30 million and delivery starting Q1 2024.

- Type: Contract
- Announced: 2023-09-26
- Where: United States
- Value: $400.0M
- Status: announced
- Products: copolymer prefillable syringe systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sharps Technology](https://endata.com/companies/11050.md) (supplier)
- [Nephron Pharmaceuticals](https://endata.com/companies/11051.md) (customer)

## Sources

- [endata.com](https://endata.com/announcements/9837-nephron-commits-to-over-400m-in-10-year-syringe-purchases-from-sharps-technology), 2023-09-26: "Nephron commits to minimum orders of over $400 Million over 10 years; $30 Million in revenue the first year"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.